| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| anavex 1007 | opioid receptor sigma 1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] melanoma[MeSHID:D008545] Pancreatic carcinoma[MeSHID:C562463] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | preclinical | unknown |
| anavex 1007 | sigma intracellular receptor 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] melanoma[MeSHID:D008545] Pancreatic carcinoma[MeSHID:C562463] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | preclinical | unknown |
| click here to return to the previous page | ||||||||